BC
AMYT

Burleson & Co’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Burleson & Co’s Portfolio AMYT Stock Details AMYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$161 Hold
22
– – ﹤0.01% 400
2022
Q3 		$0 Hold
22
– – ﹤0.01% 510
2022
Q2 		$0 Hold
22
– – ﹤0.01% 530
2022
Q1 		$0 Hold
22
– – ﹤0.01% 470
2021
Q4 		$0 Hold
22
– – ﹤0.01% 408
2021
Q3 		$0 Hold
22
– – ﹤0.01% 415
2021
Q2 		$0 Hold
22
– – ﹤0.01% 418
2021
Q1 		$0 Buy
+22
New +$307 ﹤0.01% 385

Other funds holding AMYT

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Burleson & Co's AMYT Position: Q4 2022 in Review

Burleson & Co held its Amryt Pharma plc American Depositary Shares (AMYT) position steady in Q4 2022 at 22 shares worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #400.

Burleson & Co first reported a position in AMYT in Q1 2021 and has held it in 8 quarters since. 57 funds tracked by Wall St. Rank hold AMYT as of Q4 2022.

  • Burleson & Co held 22 shares of Amryt Pharma plc American Depositary Shares worth $161 as of Q4 2022.
  • Burleson & Co left its Amryt Pharma plc American Depositary Shares share count unchanged in Q4 2022.
  • Amryt Pharma plc American Depositary Shares made up ﹤0.01% of Burleson & Co's portfolio in Q4 2022, its #400 holding.
  • Burleson & Co first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2021 and has held it in 8 quarters since.
  • 57 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.